Crossmark

Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease

Crossref DOI link: https://doi.org/10.1016/j.gastre.2021.12.005

Published Print: 2022-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Cunha-Silva, Marlone http://orcid.org/0000-0002-4424-6606
Torres, Luíza D.

Fernandes, Mariana F.

Secundo, Tirzah de M. Lopes

Moreira, Marina C.G.

Yamanaka, Ademar

Monici, Leonardo T.

Costa, Larissa B. Eloy da

Mazo, Daniel F.

Sevá-Pereira, Tiago
License Information

Text and Data Mining valid from 2022-10-01

stm-asf valid from 2022-10-01

stm-asf valid from 2022-10-01

stm-asf valid from 2022-10-01

stm-asf valid from 2022-10-01

stm-asf valid from 2022-10-01
More Information

This article is maintained by: Elsevier

Article Title: Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease

Journal Title: Gastroenterología y Hepatología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.gastre.2021.12.005

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.